Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
MA05 - Immune Landscape and Molecular Profiling of Lung Cancer
- 15:45 - 16:45
- 8/07/2022
- Location: Hall C8
- Not for CME Credit
- Type: Mini Oral
- Track: Tumor Biology and Biomarkers
- Moderators:Luis Paz-Ares, Tina Cascone
-
+
MA05.08 - MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer (NSCLC) by Specific Mutation, Histology, and Smoking History
16:17 - 16:22 | Presenter: Jennifer A. Marks
- Abstract
Loading...
-
+
EP14.05 - Small Cell Lung Cancer and Neuro-endocrine Tumors - RW/SOC
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - RW/SOC
-
+
EP14.05-016 - Patterns of Care for Small Cell Lung Cancer in Victoria Australia. A Prospective Population-Based Observational Study.
Presenter: Robert Stirling- Abstract
Loading...
-
+
P1.04 - Early Detection and Screening - Risk Stratification
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Early Detection and Screening - Risk Stratification
-
+
P1.04-03 - Independent Validation of the Maisonneuve Lung Cancer Risk Model to Optimize Screening Interval in High-risk Individuals
Presenter: Giulia Veronesi- Abstract
Loading...
-
+
P1.10 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
-
+
P1.10-02 - ImmunoPET: A Phase 0/1 Study Characterising PD-L1 with 89Zr-Durvalumab (MEDI4736) PET/CT in Stage III NSCLC Patients Receiving Chemoradiation
Presenter: Fiona Hegi-Johnson- Abstract
Loading...
-
+
MA09 - Palliative Radiotherapy: The Changing Landscape with Immunotherapy and Targeted Therapies
- 14:45 - 15:45
- 8/08/2022
- Location: Hall C7
- Not for CME Credit
- Type: Mini Oral
- Track: Metastatic Non-small Cell Lung Cancer - Palliative Radiotherapy
- Moderators:Milada Zemanova, David Ball
-
+
MA09.05 - Increased PD-L1 Tracer Uptake in Recently-irradiated Lesions in NSCLC: Preliminary Results of a Phase 0 Trial (ImmunoPET) of a Novel PET Tracer
14:57 - 15:02 | Presenter: Michael Patrick MacManus
- Abstract
Loading...
-
+
P2.03 - Metastatic Non-small Cell Lung Cancer - Palliative Radiotherapy
- 17:15 - 19:15
- 8/08/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Metastatic Non-small Cell Lung Cancer - Palliative Radiotherapy
-
+
P2.03-01 - Initial Biodistribution Data of ImmunoPET A Phase 0/1 Study Characterising PD-L1 with 89 Zr-Durvalumab (MEDI4736) PET/CT
Presenter: Fiona Hegi-Johnson- Abstract
Loading...
